Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Return on Capital Employed (2016 - 2020)

Historic Return on Capital Employed for Phio Pharmaceuticals (PHIO) over the last 8 years, with Q4 2020 value amounting to 0.59%.

  • Phio Pharmaceuticals' Return on Capital Employed rose 6600.0% to 0.59% in Q4 2020 from the same period last year, while for Dec 2020 it was 0.59%, marking a year-over-year increase of 6600.0%. This contributed to the annual value of 0.91% for FY2020, which is 100.0% up from last year.
  • As of Q4 2020, Phio Pharmaceuticals' Return on Capital Employed stood at 0.59%, which was up 6600.0% from 0.53% recorded in Q3 2020.
  • Phio Pharmaceuticals' Return on Capital Employed's 5-year high stood at 0.53% during Q3 2020, with a 5-year trough of 8.61% in Q1 2018.
  • Over the past 5 years, Phio Pharmaceuticals' median Return on Capital Employed value was 1.31% (recorded in 2016), while the average stood at 2.06%.
  • In the last 5 years, Phio Pharmaceuticals' Return on Capital Employed tumbled by -71800bps in 2018 and then surged by 80500bps in 2019.
  • Phio Pharmaceuticals' Return on Capital Employed (Quarter) stood at 1.36% in 2016, then tumbled by -268bps to 5.02% in 2017, then soared by 81bps to 0.94% in 2018, then plummeted by -33bps to 1.25% in 2019, then soared by 53bps to 0.59% in 2020.
  • Its Return on Capital Employed stands at 0.59% for Q4 2020, versus 0.53% for Q3 2020 and 0.57% for Q2 2020.